Blog / Archives

Caution on biotechs and energy

Biotech stocks were unusually weak today with many mid-caps down 3-4%. High flier CBST was down even more due to an Oppenheimer downgrade. The ELN lawsuit against Biogen regarding the Tysabri deal...

read more

Pin It on Pinterest